Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.68
- Piotroski Score 4.00
- Grade Neutral
- Symbol (HBI)
- Company Hanesbrands Inc.
- Price $7.35
- Changes Percentage (0.96%)
- Change $0.07
- Day Low $7.24
- Day High $7.40
- Year High $7.40
Hanesbrands Inc., a consumer goods company, designs, manufactures, sources, and sells a range of basic apparel for men, women, and children. The company operates through three segments: Innerwear, Activewear, and International. It sells men's underwear, women's panties, children's underwear, activewear, and socks, as well as intimate apparel, such as bras and shapewears; home goods; and T-shirts, fleece, performance apparel, sport shirts, performance T-shirts and shorts, sports bras, teamwear, and thermals, as well as licensed logo apparel in collegiate bookstores, mass retailers, and other channels. The company licenses its Champion name for footwear and sports accessories. Hanesbrands Inc. provides its products primarily under the Hanes, Champion, Maidenform, JMS/Just My Size, Bali, Polo Ralph Lauren, Playtex, DKNY, Alternative, Gear for Sports, Comfortwash, Hanes Beefy-T, Bonds, DIM, Sheridan, Bras N Things, Lovable, Wonderbra, Berlei, Abanderado, Shock Absorber, Zorba, Explorer, Sol y Oro, Maidenform, Rinbros, and Bellinda brand names. The company markets its products through retailers, wholesalers, and third-party embellishers. As of January 2, 2022, it operated 216 retail and direct outlet stores in the United States and the Commonwealth of Puerto Rico, as well as 626 retail and outlet stores internationally. The company also sells its products in Europe, Australia, Asia, Latin America, Canada, the Middle East, Africa, Mexico, and Brazil. Hanesbrands Inc. was founded in 1901 and is headquartered in Winston-Salem, North Carolina.
- Last Earnings 11/09/2022
- Ex-Dividend for 5/16 Dividend 11/21/2022
- Dividend Payable 12/13/2022
- Today N/A
- Next Earnings (Estimated) 11/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $9.50
- High Stock Price Target $12.00
- Low Stock Price Target $7.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.06
- Trailing P/E Ratio -86.33
- Forward P/E Ratio -86.33
- P/E Growth -86.33
- Net Income $-17,726,000
Income Statement
Quarterly
Annual
Latest News of HBI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Some Investors May Be Worried About Hanesbrands' (NYSE:HBI) Returns On Capital
Businesses in decline often show decreasing return on capital employed (ROCE) and capital base. Hanesbrands' declining ROCE and capital usage indicate tough times ahead. Investors should be cautious a...
By Yahoo! Finance | 1 day ago -
Justin Ishbia donates $10 million to Michigan State athletics, with baseball scoring big
Justin Ishbia, a successful businessman and sports franchise owner, values baseball as a team sport that embodies discipline and consistency. His philanthropic efforts include a $10 million donation t...
By The New York Times | 2 weeks ago -
Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Be 50% Below Their Intrinsic Value Estimate
Harvard Bioscience may be undervalued by 50% based on its current share price of US$2.88. Utilizing a Discounted Cash Flow (DCF) model, the intrinsic value was estimated at US$2.9, indicating potentia...
By Yahoo! Finance | 4 weeks ago